Mark E. Bunnage

Insider Reports History

Location
Boston, MA
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark E. Bunnage:

Company Role Class Num Shares Value Price $ Report Date Ownership
VERTEX PHARMACEUTICALS INC / MA EVP, Chief Scientific Officer Common Stock 7,284 $3,542,573 $486.35 25 Feb 2026 Direct

Insider Reports Filed by Mark E. Bunnage

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VRTX VERTEX PHARMACEUTICALS INC / MA 24 Feb 2026 2 -$583,871 4 EVP, Chief Scientific Officer 26 Feb 2026, 18:06
VRTX VERTEX PHARMACEUTICALS INC / MA 17 Feb 2026 4 -$2,289,666 4 EVP, Chief Scientific Officer 19 Feb 2026, 16:12
VRTX VERTEX PHARMACEUTICALS INC / MA 13 Feb 2026 1 -$1,113,556 4 EVP, Chief Scientific Officer 18 Feb 2026, 16:32
VRTX VERTEX PHARMACEUTICALS INC / MA 10 Feb 2026 2 -$1,458,427 4 EVP, Chief Scientific Officer 12 Feb 2026, 16:56
VRTX VERTEX PHARMACEUTICALS INC / MA 01 Feb 2026 0 $0 3 EVP, Chief Scientific Officer 03 Feb 2026, 16:09